Gather data for improved control of XDR-TB
Since it was first described in 2006, extensively drug-resistant tuberculosis (XDR-TB) has become an alarming issue in global TB control and one that seriously risks compromising progress attained in many countries over the past decade. Like many countries, Peru is facing an epidemic of XDR-TB, mainly in the capital city of Lima. The number of cases has been increasing, and cases tend to cluster in well-defined geographic areas. However, there is no clinical correlation for these cases, and no molecular epidemiology tools or spatial reference techniques have been used to understand the distribution and spread of this emerging condition.
This study funded by an IANPHI seed grant aims to describe the clinical and epidemiologic features of XDR-TB cases occurring in Peru. Results will provide evidence to improve intervention and control measures by identifying the most common modes of transmission as well as clinical manifestations and outcomes by spatial distribution, genotype, and resistance patterns.
Learn more about Peru’s Instituto Nacional de Salud >>